➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: August 7, 2020

DrugPatentWatch Database Preview

Drug Price Trends for NDC 61874-0160

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Average Pharmacy Cost for 61874-0160

Subscribe to access the full database, or Start Trial
Drug Name	NDC	Price/Unit ($)	Unit	Date
VRAYLAR 6 MG CAPSULE	61874-0160-30	39.14762	EACH	2020-06-17
VRAYLAR 6 MG CAPSULE	61874-0160-30	39.19680	EACH	2020-01-03
VRAYLAR 6 MG CAPSULE	61874-0160-30	38.42824	EACH	2019-12-18
>Drug Name	>NDC	>Price/Unit ($)	>Unit	>Date

Best Wholesale Price for NDC 61874-0160

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Subscribe to access the full database, or Start Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
VRAYLAR 6MG CAPSULE	Allergan USA, Inc	61874-0160-30	30	725.12	24.17067	2018-09-30 - 2023-09-29	Big4
VRAYLAR 6MG CAPSULE	Allergan USA, Inc	61874-0160-30	30	1182.70	39.42333	2018-09-30 - 2023-09-29	FSS
VRAYLAR 6MG CAPSULE	Allergan USA, Inc	61874-0160-30	30	803.81	26.79367	2019-01-01 - 2023-09-29	Big4
VRAYLAR 6MG CAPSULE	Allergan USA, Inc	61874-0160-30	30	1182.70	39.42333	2019-01-01 - 2023-09-29	FSS
VRAYLAR 6MG CAPSULE	Allergan USA, Inc.	61874-0160-30	30	898.79	29.95967	2020-01-01 - 2023-09-29	Big4
VRAYLAR 6MG CAPSULE	Allergan USA, Inc.	61874-0160-30	30	1182.70	39.42333	2020-01-01 - 2023-09-29	FSS
>Drug Name	>Vendor	>NDC	>Count	>Price ($)	>Price/Unit ($)	>Dates	>Price Type

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic

Merck

Moodys

Mallinckrodt

Johnson and Johnson

AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.